The Nitroglycerin Extended-Release C, cataloged under National Stock Number 6505-00-283-3200, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-283-3200 |
| Item Name | Nitroglycerin Extended-Release C |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Therapeutic Equivalent | MARION LABORATORIES |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Active Medicament Medicinal Strength | 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| NITRO-BID PLATEAU | 5/1 Secondary reference Sanofi Us Services Inc. |
| NDC00088-1551-47 | 3/9 Design control — primary reference Sanofi Us Services Inc. |
NSN 6505-00-283-3200 is a Nitroglycerin Extended-Release C, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-00-283-3200: Therapeutic Equivalent: MARION LABORATORIES; Primary Container Type: BOTTLE; Special Features: LONG ACTION METHOD:EXTENDED RELEASE;; Capsule Primary Container Content Quantity: 100.000. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.